SOL Global Investments

(OTC: SOLCF)
Healthcare  |  Drug Manufacturers - Specialty & Generic
1.63 0.03 1.87%
Stock Price | June 17, 2019, 3:48 p.m.
0 Followers
Bid: 1.6
Ask: 1.65
Prev. Close: 1.6
52 Week Low:
52 Week High:
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Scythian Biosciences Corp is a pre-clinical research and development company. It is engaged in the process of development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. In addition, it is also involved in the development of cannabinoid and non-cannabinoid based pharmaceutical products for treatment of gastro-inflammatory disease. Geographically, the activities are carried out through the region of Canada.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Weekend Edition 05/13/19

15 Comments
1 month ago

Premium Cannabis Stocks Review - Weekend Edition 05/06/19

51 Comments
1 month ago

Premium Cannabis Stocks Review - Weekend Edition 04/29/19

47 Comments
1 month ago

Premium Cannabis Stocks Review - Pre-Market Edition 04/26/19

27 Comments
1 month ago

Premium Cannabis Stocks Review - Weekend Edition 04/22/19

22 Comments
1 month ago

Premium Cannabis Stocks Review - Weekend Edition 04/15/19

9 Comments
2 months ago

Premium Toking Tuesday Chat - 04/09/19

6 Comments
2 months ago

Premium Cannabis Stocks Review - Pre-Market Edition 04/10/19

11 Comments
2 months ago

Premium Cannabis Stocks Review - Pre-Market Edition 04/09/19

14 Comments
2 months ago

Premium Cannabis Stocks Review - Weekend Edition 04/08/19

26 Comments
2 months ago